Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)

    This grant supports studies & planning for early clinical trials of gene-based therapies for ultra-rare neurological & neuromuscular disorders.

    OverviewSimilar Grants
    OverviewSimilar Grants

    Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)

    Funding support available to study and prove effectiveness of potential neurotherapeutic agents for neurological disorders towards further development.

    HHS-NIH11Due Feb 18, 2027

    Translational Neural Devices (R61/R33 - Clinical Trial Optional)

    Encourages translational activities and small clinical studies for neural devices to address disorders affecting the nervous system; includes prototype development, safety testing, and clinical validation.

    HHS-NIH11Due Jan 28, 2027

    Clinical Trials Addressing Unmet Needs of Rare Neurodegenerative Diseases (R01) Clinical Trials Required

    Funds clinical trials for new treatments or labeling changes for rare neurodegenerative diseases in adults and children, aiming to increase FDA-approved therapies.

    HHS-FDA$900,000Forecasted

    Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)

    Grant supports developing assays to find new therapies for brain and muscle diseases within IGNITE program; doesn't fund clinical trials.

    HHS-NIH11Due Feb 18, 2027$750,000

    Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed)

    This grant supports creating and validating animal models and tissue systems mimicking neurological disorders to advance neurotherapeutic discovery.

    HHS-NIH11Due Feb 18, 2027$750,000